Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 404203, 9 pages
http://dx.doi.org/10.1155/2015/404203
Research Article

Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction

1Department of Radiation Therapy, Institut Paoli Calmettes, 232 boulevard de Sainte Marguerite, 13009 Marseille, France
2Azurean Cancer Center, Mougins, France
3Department of Radiation Therapy, Timone Academic Hospital and North Academic Hospital, Marseille, France
4Department of Radiation Therapy, Val d’Aurelle Cancer Center, Montpellier, France
5Catalan Oncology Center, Perpignan, France
6French Red Cross Center, Toulon, France

Received 17 February 2015; Revised 1 June 2015; Accepted 2 June 2015

Academic Editor: Alessandro Passardi

Copyright © 2015 Laurence Moureau-Zabotto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. M. Brown, S. S. Devesa, and W.-H. Chow, “Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age,” Journal of the National Cancer Institute, vol. 100, no. 16, pp. 1184–1187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Pohl and H. G. Welch, “The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence,” Journal of the National Cancer Institute, vol. 97, no. 2, pp. 142–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. D. P. Kelsen, R. Ginsberg, T. F. Pajak et al., “Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer,” The New England Journal of Medicine, vol. 339, no. 27, pp. 1979–1984, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Stahl, M. K. Walz, M. Stuschke et al., “Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction,” Journal of Clinical Oncology, vol. 27, no. 6, pp. 851–856, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Van Hagen, M. C. C. M. Hulshof, J. J. B. van Lanschot et al., “Preoperative chemoradiotherapy for esophageal or junctional cancer,” The New England Journal of Medicine, vol. 366, no. 22, pp. 2074–2084, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Gertler, H. J. Stein, R. Langer et al., “Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the new union internationale contre le cancer/American joint cancer committee staging system,” Annals of Surgery, vol. 253, no. 4, pp. 689–698, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. V. Gebski, B. Burmeister, B. M. Smithers, K. Foo, J. Zalcberg, and J. Simes, “Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis,” Lancet Oncology, vol. 8, no. 3, pp. 226–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. Sjoquist, B. H. Burmeister, B. M. Smithers et al., “Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis,” The Lancet Oncology, vol. 12, no. 7, pp. 681–692, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. R. Siewert, A. H. Holscher, K. Becker, and W. Gossner, “Cardia cancer: attempt at a therapeutically relevant classification,” Chirurg, vol. 58, no. 1, pp. 25–32, 1987. View at Google Scholar · View at Scopus
  11. J. R. Siewert and H. J. Stein, “Classification of adenocarcinoma of the oesophagogastric junction,” British Journal of Surgery, vol. 85, no. 11, pp. 1457–1459, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Hasegawa, T. Yoshikawa, T. Aoyama et al., “Esophagus or stomach? The seventh TNM classification for siewert type II/III junctional adenocarcinoma,” Annals of Surgical Oncology, vol. 20, no. 3, pp. 773–779, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Cunningham, W. H. Allum, S. P. Stenning et al., “Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer,” The New England Journal of Medicine, vol. 355, no. 1, pp. 11–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Ychou, V. Boige, J.-P. Pignon et al., “Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial,” Journal of Clinical Oncology, vol. 29, no. 13, pp. 1715–1721, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S. E. Edge, D. R. Byrd, C. C. Compton et al., Springer, New York, NY, USA, 2009.
  16. M. Schemper and T. L. Smith, “A note on quantifying follow-up in studies of failure time,” Controlled Clinical Trials, vol. 17, no. 4, pp. 343–346, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. E. L. Kaplan and P. Meier, “Nonparametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, pp. 457–481, 1958. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet
  18. D. R. Cox, “Regression models and life-tables,” Journal of the Royal Statistical Society, Series B: Methodological, vol. 34, pp. 187–220, 1972. View at Google Scholar · View at MathSciNet
  19. B. H. Burmeister, J. M. Thomas, E. A. Burmeister et al., “Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial,” European Journal of Cancer, vol. 47, no. 3, pp. 354–360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Van Hagen, B. P. L. Wijnhoven, P. Nafteux et al., “Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer,” British Journal of Surgery, vol. 100, no. 2, pp. 267–273, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Wang, C.-Q. Yang, L.-P. Duan et al., “Changing pattern of adenocarcinoma of the esophagogastric junction in recent 10 years: experience at a large tertiary medical center in China,” Tumori, vol. 98, no. 5, pp. 568–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Ronellenfitsch, M. Schwarzbach, R. Hofheinz et al., “Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus,” Cochrane Database of Systematic Reviews, no. 5, Article ID CD008107, 2013. View at Google Scholar
  23. Y. Hosokawa, T. Kinoshita, M. Konishi et al., “Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan,” Annals of Surgical Oncology, vol. 19, no. 2, pp. 677–683, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. W.-G. Xiao, K. Ma, L. Peng, Q. Li, L.-H. Chen, and Y.-T. Han, “Characteristics of lymphatic metastasis and surgical approach of adenocarcinoma of the esophagogastric junction,” Zhonghua Wei Chang Wai Ke Za Zhi, vol. 15, no. 9, pp. 897–900, 2012. View at Google Scholar · View at Scopus
  25. M. Reeh, S. Mina, M. Bockhorn et al., “Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction,” British Journal of Surgery, vol. 99, no. 10, pp. 1406–1414, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. N. J. Curtis, F. Noble, I. S. Bailey, J. J. Kelly, J. P. Byrne, and T. J. Underwood, “The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction,” Journal of Surgical Oncology, vol. 109, no. 3, pp. 202–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Kleinberg, “Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcome,” Seminars in Radiation Oncology, vol. 23, no. 1, pp. 38–50, 2013. View at Publisher · View at Google Scholar · View at Scopus